Search

everythinglearnresearchcommunity

for

Search:↓

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Estrogen and its receptors play a key role in hair growth, with differences between males and females.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Acne is an important sign of androgen excess disorders in women.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Agmatine may help reduce seizures linked to hormone changes in female rats.

High androgen levels can cause hirsutism and increase inflammation.

Adult women with acne in Iraq often have more severe symptoms and hormone-related issues than younger girls with acne.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.